ES477977A1 - Procedimiento para la obtencion de nuevos derivados de anti-geno. - Google Patents
Procedimiento para la obtencion de nuevos derivados de anti-geno.Info
- Publication number
- ES477977A1 ES477977A1 ES477977A ES477977A ES477977A1 ES 477977 A1 ES477977 A1 ES 477977A1 ES 477977 A ES477977 A ES 477977A ES 477977 A ES477977 A ES 477977A ES 477977 A1 ES477977 A1 ES 477977A1
- Authority
- ES
- Spain
- Prior art keywords
- opt
- alkyl
- lower alkyl
- substd
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
- C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6062—Muramyl peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Procedimiento para la obtención de nuevos derivados de antígeno, compuestos de un antígeno y un péptido de muramilo covalentemente ligado con él, en caso dado a través de un miembro puente, caracterizado porque un antígeno, en caso dado enlazado con un miembro puente, se condensa con péptidos de muramilo, en caso dado enlazados con miembros puente, donde una de las dos partes lleva un grupo amino, hidroxi o mercapto libre y la otra un grupo de ácido carboxílico.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH203578 | 1978-02-24 | ||
| CH377778 | 1978-04-07 | ||
| CH539478 | 1978-05-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES477977A1 true ES477977A1 (es) | 1980-01-16 |
Family
ID=27173419
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES477977A Expired ES477977A1 (es) | 1978-02-24 | 1979-02-22 | Procedimiento para la obtencion de nuevos derivados de anti-geno. |
| ES483558A Expired ES483558A1 (es) | 1978-02-24 | 1979-08-22 | Procedimiento para la obtencion de derivados de sililgluco- saminas |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES483558A Expired ES483558A1 (es) | 1978-02-24 | 1979-08-22 | Procedimiento para la obtencion de derivados de sililgluco- saminas |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0003833B2 (es) |
| JP (1) | JPS54141718A (es) |
| AR (1) | AR223833A1 (es) |
| AT (1) | AT364718B (es) |
| AU (1) | AU527549B2 (es) |
| CA (1) | CA1138436A (es) |
| DD (1) | DD141616A5 (es) |
| DK (1) | DK161026C (es) |
| ES (2) | ES477977A1 (es) |
| FI (1) | FI66878C (es) |
| GB (1) | GB2015534A (es) |
| GR (1) | GR77615B (es) |
| HU (1) | HU182011B (es) |
| IL (1) | IL56724A (es) |
| NO (2) | NO151201C (es) |
| NZ (1) | NZ189756A (es) |
| PL (1) | PL123315B1 (es) |
| PT (1) | PT69281A (es) |
| SU (1) | SU1055312A3 (es) |
| ZA (1) | ZA79893B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54130516A (en) * | 1978-03-31 | 1979-10-09 | Yuuichi Yamamura | Acyllnnacetylmuramylpeptide derivativeeantigen combination |
| FR2428051A1 (fr) * | 1978-06-05 | 1980-01-04 | Anvar | Nouveaux composes du type muramyl-peptide et medicaments les contenant |
| FR2428050A1 (fr) * | 1978-06-05 | 1980-01-04 | Anvar | Oligomeres de composes du type muramyl-peptide et medicaments les contenant |
| DE2965017D1 (en) | 1978-12-22 | 1983-04-14 | Anvar | New compounds associating peptidyl or aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds |
| FR2446292A1 (fr) * | 1979-01-12 | 1980-08-08 | Anvar | Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant |
| FR2449697A1 (fr) | 1979-02-20 | 1980-09-19 | Anvar | Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant |
| JPS5618996A (en) * | 1979-06-21 | 1981-02-23 | Dai Ichi Seiyaku Co Ltd | Muramyldipeptide derivative |
| DK156252C (da) * | 1979-07-31 | 1989-12-18 | Fujisawa Pharmaceutical Co | Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf |
| US4406889A (en) | 1980-02-15 | 1983-09-27 | Ciba-Geigy Corporation | Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use |
| EP0038153A3 (en) * | 1980-04-15 | 1982-12-22 | Beecham Group Plc | Modified allergens |
| US4368190A (en) * | 1980-04-17 | 1983-01-11 | Merck & Co., Inc. | Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation |
| US4497729A (en) * | 1980-12-01 | 1985-02-05 | Fujisawa Pharmaceutical Co., Ltd. | Peptide, process for preparation thereof and use thereof |
| FR2522967B1 (fr) * | 1982-03-15 | 1986-03-07 | Anvar | Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant |
| US4587046A (en) * | 1982-05-18 | 1986-05-06 | The Regents Of The University Of California | Drug-carrier conjugates |
| FR2558165B1 (fr) * | 1984-01-17 | 1986-07-04 | Anvar | Nouveaux conjugues d'oligo-muramylpeptides et compositions biologiques les contenant pour l'activation des macrophages |
| FR2569984B1 (fr) * | 1984-09-12 | 1987-08-14 | Anvar | Molecule synthetique contenant une pluralite d'epitopes distincts, procede pour son obtention et application a la production de polyvaccins |
| WO2017190145A1 (en) | 2016-04-29 | 2017-11-02 | Icahn School Of Medicine At Mount Sinai | Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis |
| EP3636656A4 (en) | 2017-06-09 | 2021-04-14 | Chugai Seiyaku Kabushiki Kaisha | METHOD OF SYNTHESIS OF PEPTIDE WITH N-SUBSTITUTED AMINO ACID |
| CN119143631A (zh) * | 2018-11-30 | 2024-12-17 | 中外制药株式会社 | 用于肽化合物或酰胺化合物的脱保护方法和在固相反应中的树脂脱除方法以及用于生产肽化合物的方法 |
| CN118459539B (zh) | 2021-03-19 | 2026-01-06 | 生物治疗探索股份有限公司 | 用于调节训练免疫的化合物及其使用方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH564031A5 (es) * | 1968-03-29 | 1975-07-15 | Anvar | |
| US4186194A (en) * | 1973-10-23 | 1980-01-29 | Agence Nationale De Valorisation De La Recherche (Anvar) | Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents |
| CH613709A5 (en) * | 1975-12-10 | 1979-10-15 | Ciba Geigy Ag | Process for the preparation of glucosamine derivatives |
| GB1573126A (en) * | 1976-03-10 | 1980-08-13 | Anvar | Immunising and anti-infectious adjuvant agents comprising peptide derivatives of muramic acid |
| FR2343482A1 (fr) * | 1976-03-10 | 1977-10-07 | Anvar | La 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-seryl-d-isoglutamine et medicaments la contenant |
-
1979
- 1979-02-21 FI FI790584A patent/FI66878C/fi not_active IP Right Cessation
- 1979-02-21 EP EP79100513A patent/EP0003833B2/de not_active Expired - Lifetime
- 1979-02-21 CA CA000321992A patent/CA1138436A/en not_active Expired
- 1979-02-22 IL IL7956724A patent/IL56724A/xx not_active IP Right Cessation
- 1979-02-22 GR GR58433A patent/GR77615B/el unknown
- 1979-02-22 ES ES477977A patent/ES477977A1/es not_active Expired
- 1979-02-23 DK DK079779A patent/DK161026C/da not_active IP Right Cessation
- 1979-02-23 HU HU79CI1917A patent/HU182011B/hu unknown
- 1979-02-23 AU AU44546/79A patent/AU527549B2/en not_active Expired
- 1979-02-23 SU SU792739298A patent/SU1055312A3/ru active
- 1979-02-23 DD DD79211204A patent/DD141616A5/de unknown
- 1979-02-23 NZ NZ189756A patent/NZ189756A/xx unknown
- 1979-02-23 NO NO79790626A patent/NO151201C/no unknown
- 1979-02-23 ZA ZA79893A patent/ZA79893B/xx unknown
- 1979-02-23 AT AT0142079A patent/AT364718B/de not_active IP Right Cessation
- 1979-02-23 PT PT69281A patent/PT69281A/pt unknown
- 1979-02-24 JP JP2128179A patent/JPS54141718A/ja active Granted
- 1979-02-24 PL PL1979213696A patent/PL123315B1/pl unknown
- 1979-02-26 GB GB7906649A patent/GB2015534A/en not_active Withdrawn
- 1979-02-26 AR AR275626A patent/AR223833A1/es active
- 1979-08-22 ES ES483558A patent/ES483558A1/es not_active Expired
- 1979-12-07 NO NO79793993A patent/NO151088C/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2031806T3 (es) | Factor de permeabilidad vascular humano. | |
| DE3583008D1 (de) | Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren. | |
| AR017866A1 (es) | Metodo para incrementar las inmunorespuestas de vacunas de acidos nucleicos, composiciones farmaceuticas de aplicacion en dicho metodo, procedimientopara preparar dichas composiciones y vacunas utilizadas en dicho metodo. | |
| FI932561A7 (fi) | Proteiinit, joilla on muuttuneet epitoopit ja menetelmiä niiden valmistamiseksi | |
| FI811745A7 (fi) | Farmaseuttinen seos ja menetelmä sen valmistamiseksi. | |
| BR0008741A (pt) | Peptìdeo de hiv, antìgenos, composições de vacina, kit de imunoensaio e método de detecção de anticorpos induzidos por hiv | |
| SE8103594L (sv) | N-(vinblastin-23-oyl)aminosyraderivat | |
| ES554155A0 (es) | Un procedimiento para la preparacion de un proteina envolvente de un virus de sindrome de inmunodeficiencia adquirida | |
| DK362786A (da) | Fremgangsmaade og midler til fremstilling af liposomer | |
| SE8804164A0 (sv) | Farmaceutisk beredning | |
| FI860878A7 (fi) | Aminohappojohdokset ja menetelmä niiden valmistamiseksi. | |
| FI803849A7 (fi) | Uudet asyylipeptidit, niistä valmistetut farmaseuttiset valmisteet, menetelmä niiden valmistamiseksi ja niiden käyttö. | |
| PT88086A (pt) | Processo para a preparacao de composicoes farmaceuticas a base de sais de alfa-aminoacidos basicos e de alfa-ceto-analogos de aminoacidos de cadeia ramificada apropriadas para o tratamento da uremia | |
| IT1177889B (it) | Proteine umane,antisieri per esse,procedimento per prepararli e corre di di prova che li contengono | |
| ATE46703T1 (de) | Regionspezifische determinanten fuer vitamin-k abhaengiges knochenprotein. | |
| FI921562A7 (fi) | Gem-difosfonihapot, menetelmä niiden valmistamiseksi ja farmaseuttiset koostumukset, jotka sisältävät niitä | |
| DK330585A (da) | Kombinationspraeparat af pyrimido-pyrimidiner og 0-acetylsalicylsyre og deres farmaceutisk acceptable salte | |
| BG97123A (bg) | Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа | |
| FR2601679B1 (fr) | Immunotoxines, procede de preparation et compositions pharmaceutiques en contenant | |
| IT8025883A0 (it) | Derivato della glicina,metodo per la sua preparazione e composizioni farmaceutiche che lo contengono | |
| DE69129747D1 (de) | In lösung bringen von proteinen in aktiver form | |
| ATA363479A (de) | Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen | |
| ES2056149T3 (es) | Ambliommina, una nueva sustancia activa para la terapia anticoagulante. | |
| FI884225A7 (fi) | Uusia aminohappoestereitä, menetelmiä niiden valmistamiseksi, niitä sisältäviä lääkeaineita ja niiden käyttö. | |
| JPS55141452A (en) | Synthetic polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970519 |